These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3327665)

  • 21. Apolipoprotein polymorphisms fail to define risk of coronary artery disease. Results of a prospective, angiographically controlled study.
    Marshall HW; Morrison LC; Wu LL; Anderson JL; Corneli PS; Stauffer DM; Allen A; Karagounis LA; Ward RH
    Circulation; 1994 Feb; 89(2):567-77. PubMed ID: 8313545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial.
    Brousseau ME; O'Connor JJ; Ordovas JM; Collins D; Otvos JD; Massov T; McNamara JR; Rubins HB; Robins SJ; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1148-54. PubMed ID: 12117730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoproteins, quantitative lipoprotein traits and multifactorial hyperlipidaemia.
    Utermann G
    Ciba Found Symp; 1987; 130():52-69. PubMed ID: 2965000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apolipoprotein A5 gene polymorphism -1131T-->C: association with plasma lipids and type 2 diabetes mellitus with coronary heart disease in Chinese.
    Yan SK; Cheng XQ; Song YH; Xiao XH; Bi N; Chen BS
    Clin Chem Lab Med; 2005; 43(6):607-12. PubMed ID: 16006256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein genetic variation in the assessment of atherosclerosis susceptibility.
    Hegele RA; Breslow JL
    Genet Epidemiol; 1987; 4(3):163-84. PubMed ID: 2886398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The genetic contribution to coronary disease. The genetic factors related to lipid metabolism].
    da Silva PM
    Rev Port Cardiol; 1999; 18(7-8):735-47. PubMed ID: 10466375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genotype by sex interaction in measures of lipids, lipoproteins, and apolipoproteins.
    Towne B; Blangero J; Siervogel RM
    Genet Epidemiol; 1993; 10(6):611-6. PubMed ID: 8314069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apolipoprotein A-IV protein polymorphism: frequency and effects on lipids, lipoproteins, and apolipoproteins among Mexican-Americans in Starr County, Texas.
    Hanis CL; Douglas TC; Hewett-Emmett D
    Hum Genet; 1991 Jan; 86(3):323-5. PubMed ID: 1997391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic contributions to quantitative lipoprotein traits associated with coronary artery disease: analysis of a large pedigree from the Bogalusa Heart Study.
    Heiba IM; DeMeester CA; Xia YR; Diep A; George VT; Amos CI; Srinivasan SR; Berenson GS; Elston RC; Lusis AJ
    Am J Med Genet; 1993 Nov; 47(6):875-83. PubMed ID: 8279486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of apolipoprotein E gene plasma levels of lipids, lipoproteins, apolipoproteins and its relation with coronary heart disease].
    Zhu T; Wang Z; Zhao S
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(2):149-51. PubMed ID: 10681829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Restriction fragment length polymorphisms of the apolipoprotein A-I, C-III, A-IV gene locus. Relationships with lipids, apolipoproteins, and premature coronary artery disease.
    Ordovas JM; Civeira F; Genest J; Craig S; Robbins AH; Meade T; Pocovi M; Frossard PM; Masharani U; Wilson PW
    Atherosclerosis; 1991 Mar; 87(1):75-86. PubMed ID: 1678604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Common genetic variants that relate to disorders of lipid transport in Spanish subjects with premature coronary artery disease.
    Masana L; Febrer G; Cavanna J; Baroni MG; Marz W; Hoffmann MM; Shine B; Galton DJ
    Clin Sci (Lond); 2001 Feb; 100(2):183-90. PubMed ID: 11171287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Familial aggregation of non-insulin dependent diabetes and coronary heart disease are accompanied by different effects on serum lipids, lipoproteins and apolipoproteins.
    Sarlund H; Laakso M; Voutilainen E; Penttilä I; Pyörälä K
    Atherosclerosis; 1991 Jan; 86(1):17-29. PubMed ID: 2064632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic variation in the apolipoprotein AI-CIII-AIV gene cluster and coronary heart disease.
    Paulweber B; Friedl W; Krempler F; Humphries SE; Sandhofer F
    Atherosclerosis; 1988 Oct; 73(2-3):125-33. PubMed ID: 2903749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymorphism of the apolipoprotein A-IV gene and its significance in lipid metabolism and coronary heart disease in a Japanese population.
    Bai H; Saku K; Liu R; Oribe Y; Yamamoto K; Arakawa K
    Eur J Clin Invest; 1996 Dec; 26(12):1115-24. PubMed ID: 9013087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of measured genotype information in the analysis of quantitative phenotypes in man. II. The role of the apolipoprotein E polymorphism in determining levels, variability, and covariability of cholesterol, betalipoprotein, and triglycerides in a sample of unrelated individuals.
    Boerwinkle E; Visvikis S; Welsh D; Steinmetz J; Hanash SM; Sing CF
    Am J Med Genet; 1987 Jul; 27(3):567-82. PubMed ID: 3631131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetics of lipoprotein abnormalities associated with coronary artery disease susceptibility.
    Breslow JL
    Annu Rev Genet; 2000; 34():233-254. PubMed ID: 11092828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study.
    Russo GT; Meigs JB; Cupples LA; Demissie S; Otvos JD; Wilson PW; Lahoz C; Cucinotta D; Couture P; Mallory T; Schaefer EJ; Ordovas JM
    Atherosclerosis; 2001 Sep; 158(1):173-81. PubMed ID: 11500189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetics of variability of CHD risk.
    Sing CF; Moll PP
    Int J Epidemiol; 1989; 18(3 Suppl 1):S183-95. PubMed ID: 2807701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Genetic polymorphism of the E apolipoprotein in school age children: comparison with levels of plasma lipids and apolipoproteins].
    Callas N; Poveda E; Baracaldo C; Hernández P; Castillo C; Guerra M
    Biomedica; 2007 Dec; 27(4):526-36. PubMed ID: 18320120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.